CCK2-receptor-targeting-tubulysin B conjugates (Endocyte)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCCK2-receptor-targeting-tubulysin B conjugates (Endocyte)
Drug Alias NameEC-1873EC-1868EC-1947
ClassificationRadiation-emitting productsDiagnostic agent (In vivo)Small molecules
Mechanisms of ActionCholecystokinin B receptor modulators
TargetsCholecystokinin B receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEndocyte Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEndocyte Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A